drugset / Trial / NCT01547559

Research for Prevention and Treatment of NSAIDs Related Gastrointestinal Side Effects

NCT01547559 ↗

Unknown 369 enrolled Sun Yat-sen University
RandomizedParallel-groupSingle-blindPrevention

Summary

We aim to evaluate the protective effects of eradication of HP and continue using Geranylgeranylacetone (GGA) on NSAIDs related gastroenterological lesions. We further aim to explore the effect of GGA on small-intestinal mucosal injuries induced by diclofenac sodium in patients with rheumatic diseases who didn't take NSAIDs in the preceding 6 months.

Timeline

Start
2007-06
Primary completion
2014-11
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified 1 g —
Subject Clarithromycin Small molecule 500 mg —
Subject Esomeprazole Small molecule 20 mg —
Subject Metronidazole Small molecule 500 mg —
Subject Teprenone Unknown 50 mg —
Background Diclofenac Other / unclassified 75 mg —

Indications